SS
Sunny Sharma
About Sunny Sharma
Data last updated:
Sunny Sharma is a Director at Marksans Pharma Limited (since 2021), Director at Advanced Enzyme Technologies Limited (since 2019) and Nominee Director at Adret Retail Private Limited (since 2022), and holds 5 more current directorships. The companies operate in Pharma, Chemicals and Materials and Healthcare. The 7 current companies with reported revenue have a combined latest revenue of ₹4,878 Cr; the largest is Marksans Pharma Limited at ₹3,033 Cr (FY 2026). Earlier, Sunny Sharma was a Director at Lifewell Diagnostics Private Limited (2022–2024) and Nominee Director at Blue Sapphire Healthcares Private Limited (2014–2023) and 23 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Marksans Pharma Limited L24110MH1992PLC066364 | Director | 11 Aug 2021 | 1992 | ₹3,033 Cr (FY 2026) | Active |
 Advanced Enzyme Technologies Limited L24200MH1989PLC051018 | Director | 02 Nov 2019 | 1989 | ₹670 Cr (FY 2025) | Active |
 Adret Retail Private Limited U52100KA2015PTC196406 | Nominee Director | 02 Nov 2022 | 2015 | ₹349 Cr (FY 2025) | Active |
 Innvolution Healthcare Private Limited U74999KA2011PTC174870 | Nominee Director | 19 Apr 2023 | 2011 | ₹323 Cr (FY 2025) | Active |
 Lifecell International Private Limited U85196TN2004PTC053577 | Director | 22 Sep 2021 | 2004 | ₹279 Cr (FY 2024) | Active |
 Arcatron Mobility Private Limited U29299PN2015PTC155291 | Nominee Director | 19 Feb 2024 | 2015 | ₹178 Cr (FY 2025) | Active |
 Orbimed Advisors India Private Limited U67120MH2008FTC186971 | Director | 23 Sep 2008 | 2008 | ₹45.73 Cr (FY 2025) | Active |
 Lattice Medtech Private Limited U32509HR2024PTC125504 | Nominee Director | 13 Mar 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Lifewell Diagnostics Private Limited U85100TN2022PTC150858 | Director | 09 May 2022 | 2022 | ₹24.02 Cr (FY 2023) | Active |
 Blue Sapphire Healthcares Private Limited U74999DL2007PTC159674 | Nominee Director | 09 Jan 2014 | 2007 | ₹490 Cr (FY 2025) | Active |
 Laxmi Dental Limited L51507MH2004PLC147394 | Director | 07 Feb 2015 | 2004 | ₹242 Cr (FY 2025) | Active |
 Suraksha Diagnostic Limited L85110WB2005PLC102265 | Nominee Director | 29 Dec 2016 | 2005 | ₹12.21 Cr (FY 2025) | Active |
 Entero Healthcare Solutions Limited L74999HR2018PLC072204 | Director | 24 Aug 2018 | 2018 | ₹6,610 Cr (FY 2026) | Active |
 Kims Kottayam Institute Of Medical Sciences Private Limited U85110KL2010PTC026107 | Director | 20 Apr 2013 | 2010 | ₹25.22 Cr (FY 2025) | Active |
 Bharat Serums And Vaccines Limited U24230MH1971PLC015134 | Director | 24 Mar 2010 | 1971 | ₹1,455 Cr (FY 2023) | Amalgamated |
 Surya Children's Medicare Private Limited U85100MH2010PTC203093 | Nominee Director | 23 Jul 2013 | 2010 | ₹200 Cr (FY 2023) | Active |
 Shasun Pharmaceuticals Limited L24117TN1976PLC007122 | Director | 29 Mar 2012 | 1976 | ₹1,329 Cr (FY 2015) | Amalgamated |
 Kims Health Care And Research Center Limited U85110KL2007PLC020344 | Nominee Director | 15 Dec 2011 | 2007 | Amalgamated | |
 Innovation Imaging Technologies Private Limited U33110KA2016PTC087188 | Nominee Director | 07 Jul 2023 | 2016 | ₹195 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunny Sharma
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunny Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunny Sharma
Sunny Sharma currently holds 8 directorships: Marksans Pharma Limited (Director, since 11 Aug 2021, revenue ₹3,033 Cr (FY 2026)); Advanced Enzyme Technologies Limited (Director, since 02 Nov 2019, revenue ₹670 Cr (FY 2025)); Adret Retail Private Limited (Nominee Director, since 02 Nov 2022, revenue ₹349 Cr (FY 2025)); Innvolution Healthcare Private Limited (Nominee Director, since 19 Apr 2023, revenue ₹323 Cr (FY 2025)); Lifecell International Private Limited (Director, since 22 Sep 2021, revenue ₹279 Cr (FY 2024)); and 3 more.
Sunny Sharma was first appointed on 23 Sep 2008 as Director at Orbimed Advisors India Private Limited. The most recent appointment on record is 13 Mar 2025 at Lattice Medtech Private Limited.
The 7 current companies of Sunny Sharma that report revenue have a combined latest revenue of ₹4,878 Cr: Marksans Pharma Limited ₹3,033 Cr (FY 2026); Advanced Enzyme Technologies Limited ₹670 Cr (FY 2025); Adret Retail Private Limited ₹349 Cr (FY 2025); Innvolution Healthcare Private Limited ₹323 Cr (FY 2025); Lifecell International Private Limited ₹279 Cr (FY 2024); and 2 more.
Sunny Sharma held 25 earlier board appointments: Lifewell Diagnostics Private Limited (Director, 09 May 2022 to 30 Jun 2024); Blue Sapphire Healthcares Private Limited (Nominee Director, 09 Jan 2014 to 12 Oct 2023); Laxmi Dental Limited (Director, 07 Feb 2015 to 28 Aug 2023); Suraksha Diagnostic Limited (Nominee Director, 29 Dec 2016 to 28 Aug 2023); Entero Healthcare Solutions Limited (Director, 24 Aug 2018 to 23 Aug 2023); and 20 more.
The current boards of Sunny Sharma's companies include Abhinna Mohanty Sundar (Marksans Pharma Limited), Digant Mahesh Parikh (Marksans Pharma Limited), Harshavardhan Panigrahi (Marksans Pharma Limited), Jitendra Mahabirprasad Sharma (Marksans Pharma Limited), Mark Saldanha (Marksans Pharma Limited), Sandra Saldanha (Marksans Pharma Limited), among others.